Mize 2004.

Methods	A patient report of headache and mild depression during methylphenidate treatment
Participants	Diagnosis of ADHD: DSM‐IV (subtype: not stated) Age: 12 years and 3 months old IQ: 124 Sex: male Ethnicity: not stated Country: USA Comorbidity: none stated Comedication: not stated Sociodemographics: not stated
Interventions	Methylphenidate type: Ritalin slow release Methylphenidate dosage: 20 mg/daily Administration schedule: not stated Duration of treatment: not stated Treatment compliance: not stated
Outcomes	Non‐serious adverse events: Headache and symptoms of mild depression
Notes	Key conclusions of the study authors: 10 sessions of haemoencephalograph appear to have produced significant change in attention Comments from the review authors: the study shortly comments that the boy has headache and symptoms of mild depression when taking methylphenidate (20 mg/daily) Funding/vested interest/authors' affiliations: not stated